CUV

0.67%

$14.72 clinuvel pharmaceuticals limited

Agree 100%.Maybe they are not against shorts, if you have a...

First 4 Last

Share
Profile

Follow
skram1182

1,290 Posts.

115

13/12/23

14:25

Post #: 71427538
Share

Originally posted by Silverchair: ↑

I'm not telling you anything new, I will try just to mention facts in the following paragraph:

Every single day ASIC data shows how highly manipulated CUV is. Short selling and the introduction of fake liquidity is done to control the price and absorb any buying pressure to maintain/manipulate the price (illegally IMO). The DOW and S&P are at very high levels yet CUV is near 5 year lows. The price of CUV is down about 25% in one year and about 10% for last 5 years. Company performing well with profits and growth and cash around $160 Million sitting idle - yet the financial fur of CUV is doing little to protect shareholders. The AGM did not make a single mention of short selling interest in this stock either long term or daily yet this is what has largely brought the price to where it is today. Timelines are rarely met and communication is weird and unlike any other company I have ever dealt with, for example is the recently mentioned goal of household name by Jan 2026 still being striven for?

.

Basically it has come to the point where I believe many shareholders don't care to differentiate any longer between company performance and share price performance. This is what short sellers want, and seemingly what the company is willing to accept, as any arguments they make about price performance are simply frail or totally miss the point. They just received a massive first strike at the AGM and are on track for a 2nd as short sellers will be hoping/striving for. The company by simply doing the same old stuff like comparing performance to MSB (which had a FDA rejection and would have tanked in any environment) and ignoring the short sellers will get the same old results. Ignoring shorting has not worked at any period for the last 5 years and the only way to respond to that and protect shareholder interests is by performing a substantial share buyback - which would still only use a tiny percentage of cash on hand and would give everlasting benefits to the company financials and EPS.

The board just needs to ask the question if it is in shareholder interests that over the last several years that more than 2 Million fake liquidity short positions have been created in CUV and all of them with the intention to drive the share price lower? CUV was also driven from the ASX200 and was this in shareholder or the company interests?
Shorters will try to never allow CUV back into the ASX200 while they are manipulating the price. The shorters have never gone away for a single day and I doubt they will unless they are driven away like PME and COH have done by running share buybacks. COH has a P/E about 65 and PME more than double that at over 130. CUV lagging at around low 20s.

All IMO DYOR

Expand

Agree 100%.
Maybe they are not against shorts, if you have a large number of CUV shares, you can make money out of loaning to shorts.

CUV Price at posting: $16.37 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

There are more pages in this discussion • 10 more messages in this thread...

First 4 Last

Add CUV (ASX) to my watchlist

(20min delay)
Last $14.72		Change -0.100(0.67%)		Mkt cap ! $737.1M

Open	High	Low	Value	Volume
$14.80	$14.97	$14.60	$600.3K	40.64K

Buyers (Bids)

No.	Vol.	Price($)
2	324	$14.69

Sellers (Offers)

Price($)	Vol.	No.
$14.75	100	1

View Market Depth

No.	Vol.	Price($)
2	324	14.690
1	324	14.660
1	324	14.640
1	324	14.610
1	20	14.600

Price($)	Vol.	No.
14.750	100	1
14.840	324	1
14.860	324	1
14.890	324	1
14.920	324	1

Last trade - 16.10pm 06/09/2024 (20 minute delay)

CUV (ASX) Chart

Agree 100%.Maybe they are not against shorts, if you have a...

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Agree 100%.Maybe they are not against shorts, if you have a...

Top Stories

Shekel Brainweigh investor presentation webinar – the future of retail automation

As Nvidia cools, we're looking to Aussie AI

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

CBA breaks trading record on strong day for Aussie financials

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News